NorthCrest Asset Manangement’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.2M Buy
17,429
+906
+5% +$926K 0.54% 41
2026
Q1
$15.5M Sell
16,523
-3,929
-19% -$3.98M 0.48% 54
2025
Q4
$21.3M Sell
20,452
-67
-0.3% -$64.1K 0.48% 55
2025
Q3
$17.3M Buy
20,519
+882
+4% +$656K 0.41% 73
2025
Q2
$15.3M Sell
19,637
-30
-0.2% -$23.3K 0.41% 71
2025
Q1
$16.2M Buy
19,667
+1,541
+9% +$1.28M 0.49% 64
2024
Q4
$14M Buy
18,126
+11,280
+165% +$9.34M 0.42% 72
2024
Q3
$6.07M Buy
6,846
+655
+11% +$589K 0.18% 126
2024
Q2
$5.61M Buy
6,191
+67
+1% +$53.6K 0.19% 132
2024
Q1
$4.76M Sell
6,124
-108
-2% -$76.9K 0.16% 148
2023
Q4
$3.63M Sell
6,232
-15
-0.2% -$8.76K 0.14% 158
2023
Q3
$3.36M Buy
6,247
+233
+4% +$120K 0.14% 160
2023
Q2
$2.82M Buy
6,014
+2,031
+51% +$852K 0.11% 167
2023
Q1
$1.37M Buy
3,983
+385
+11% +$130K 0.06% 214
2022
Q4
$1.32M Sell
3,598
-304
-8% -$108K 0.07% 153
2022
Q3
$1.26M Sell
3,902
-26
-0.7% -$8.24K 0.07% 178
2022
Q2
$1.27M Hold
3,928
0.07% 184
2022
Q1
$1.13M Buy
3,928
+131
+3% +$33.7K 0.05% 189
2021
Q4
$1.05M Buy
+3,797
New +$963K 0.06% 216

Other funds holding LLY

NorthCrest Asset Manangement's LLY Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its Eli Lilly (LLY) stake by 5.5% in Q2 2026, buying an estimated $926K and bringing the position to 17,429 shares worth $21.2M. The position accounts for 0.54% of the portfolio, ranked #41.

NorthCrest Asset Manangement first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $21.3M in Q4 2025. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • NorthCrest Asset Manangement held 17,429 shares of Eli Lilly worth $21.2M as of Q2 2026.
  • NorthCrest Asset Manangement bought 906 Eli Lilly shares in Q2 2026, an estimated $926K.
  • Eli Lilly made up 0.54% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #41 holding.
  • NorthCrest Asset Manangement first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • NorthCrest Asset Manangement's Eli Lilly position peaked at $21.3M in Q4 2025.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.